Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery

Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of ma...

Full description

Saved in:
Bibliographic Details
Published inMolecular pharmaceutics Vol. 6; no. 5; pp. 1417 - 1428
Main Authors Häfeli, Urs O, Riffle, Judy S, Harris-Shekhawat, Linda, Carmichael-Baranauskas, Anita, Mark, Framin, Dailey, James P, Bardenstein, David
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 05.10.2009
Subjects
Online AccessGet full text
ISSN1543-8384
1543-8392
DOI10.1021/mp900083m

Cover

Abstract Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application.
AbstractList Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application.
Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application.Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such in vivo applications, the magnetic drug carrier must be biocompatible and nontoxic. In this work, we investigated the toxic properties of magnetic nanoparticles coated with polyethylenoxide (PEO) triblock copolymers. Such coatings prevent the aggregation of magnetic nanoparticles and guarantee consistent magnetic and nonmagnetic flow properties. It was found that the PEO tail block length inversely correlates with toxicity. The nanoparticles with the shortest 0.75 kDa PEO tails were the most toxic, while particles coated with the 15 kDa PEO tail block copolymers were the least toxic. Toxicity responses of the tested prostate cancer cell lines (PC3 and C4-2), human umbilical vein endothelial cells (HUVECs), and human retinal pigment epithelial cells (HRPEs) were similar. Furthermore, all cell types took up the coated magnetic nanoparticles. It is concluded that magnetite nanoparticles coated with triblock copolymers containing PEO tail lengths of above 2 kDa are biocompatible and appropriate for in vivo application.
Author Häfeli, Urs O
Dailey, James P
Bardenstein, David
Carmichael-Baranauskas, Anita
Mark, Framin
Riffle, Judy S
Harris-Shekhawat, Linda
Author_xml – sequence: 1
  givenname: Urs O
  surname: Häfeli
  fullname: Häfeli, Urs O
  email: uhafeli@interchange.ubc.ca
– sequence: 2
  givenname: Judy S
  surname: Riffle
  fullname: Riffle, Judy S
– sequence: 3
  givenname: Linda
  surname: Harris-Shekhawat
  fullname: Harris-Shekhawat, Linda
– sequence: 4
  givenname: Anita
  surname: Carmichael-Baranauskas
  fullname: Carmichael-Baranauskas, Anita
– sequence: 5
  givenname: Framin
  surname: Mark
  fullname: Mark, Framin
– sequence: 6
  givenname: James P
  surname: Dailey
  fullname: Dailey, James P
– sequence: 7
  givenname: David
  surname: Bardenstein
  fullname: Bardenstein, David
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19445482$$D View this record in MEDLINE/PubMed
BookMark eNqFkUlLxTAUhYMozgv_gGQj4uJpxrZZyntO4LBw2JbbNJVom9QkFd-_t_IcQARX9yy-c-Ccu4GWnXcGoR1KDilh9KjrFSGk4N0SWqdS8EnBFVv-1oVYQxsxPhHChGR8Fa1RJYQUBVtHD1PTtvi-T_BsMLgaW4cfbAoe3_k3q22aY9_gK3h0JlmNr8H5HsIoWxPx7WATVK3BjQ94FoZHPDOtfTVhvoVWGmij2f68m-j-9ORuej65vDm7mB5fToCLLE0YoxpqqmQuadVUXCilNLCaKMGaOtOsKDSlwHKQnCiSFVUuCFOgMp7lSlC-ifYXuX3wL4OJqexs1GMlcMYPscylkJKwsfW_JBckUxn9yNz9JIeqM3XZB9tBmJdfo43AwQLQwccYTPODkPLjIeX3Q0b26Bc7bgrJepcC2PZPx97CATqWT34IbhzwD-4dXlqWcw
CitedBy_id crossref_primary_10_3390_nano11092255
crossref_primary_10_1016_j_toxrep_2014_11_002
crossref_primary_10_1007_s13530_017_0299_z
crossref_primary_10_3390_ijerph19138171
crossref_primary_10_1007_s10876_017_1256_3
crossref_primary_10_1007_s11051_011_0516_7
crossref_primary_10_1016_j_jconrel_2011_12_006
crossref_primary_10_1016_j_apsadv_2022_100303
crossref_primary_10_1016_j_jksus_2023_102689
crossref_primary_10_1002_biot_201100100
crossref_primary_10_1007_s11051_016_3455_5
crossref_primary_10_3390_nano10061018
crossref_primary_10_1016_j_cej_2015_04_152
crossref_primary_10_1021_nn300902w
crossref_primary_10_1016_j_jhazmat_2015_10_041
crossref_primary_10_1155_2014_287575
crossref_primary_10_1007_s11051_013_1874_0
crossref_primary_10_1186_s11671_018_2457_x
crossref_primary_10_1002_sia_4929
crossref_primary_10_1016_j_toxrep_2021_01_012
crossref_primary_10_1016_j_aquatox_2024_107218
crossref_primary_10_1039_c3ra40462e
crossref_primary_10_1016_j_biomaterials_2010_04_062
crossref_primary_10_1016_j_jmmm_2014_10_041
crossref_primary_10_1186_1556_276X_7_210
crossref_primary_10_1155_2012_548389
crossref_primary_10_1002_jbm_a_34797
crossref_primary_10_1021_acs_inorgchem_6b03143
crossref_primary_10_1021_acs_jpcb_0c08089
crossref_primary_10_1088_0964_1726_25_1_015022
crossref_primary_10_1007_s11051_023_05716_3
crossref_primary_10_1021_ac9014534
crossref_primary_10_1007_s10529_019_02699_x
crossref_primary_10_3109_02656736_2013_835876
crossref_primary_10_1021_acsbiomaterials_7b00839
crossref_primary_10_1016_j_jconrel_2017_04_003
crossref_primary_10_1080_17435390_2019_1650969
crossref_primary_10_1007_s10499_022_00870_2
crossref_primary_10_1016_j_ijbiomac_2019_10_272
crossref_primary_10_1021_jp109258f
crossref_primary_10_1039_D0RA04220J
crossref_primary_10_1016_S1734_1140_12_70901_5
crossref_primary_10_1186_s12951_021_01059_0
crossref_primary_10_1016_j_biomaterials_2016_06_007
crossref_primary_10_1016_j_lfs_2019_01_056
crossref_primary_10_3233_BSI_200205
crossref_primary_10_1016_j_nantod_2011_10_001
crossref_primary_10_4155_tde_11_48
crossref_primary_10_1016_j_etap_2013_07_005
crossref_primary_10_20535_ibb_2024_8_1_288067
crossref_primary_10_3390_cryst14080696
crossref_primary_10_1007_s00204_011_0773_3
crossref_primary_10_1007_s12668_024_01666_9
crossref_primary_10_3390_ijms12118288
crossref_primary_10_1002_app_37892
crossref_primary_10_1177_0748233720977383
crossref_primary_10_2174_0122117385277725231120043600
crossref_primary_10_3762_bjnano_12_22
crossref_primary_10_1016_j_colsurfb_2012_09_019
crossref_primary_10_2217_nnm_15_14
crossref_primary_10_1039_C3DT52377B
crossref_primary_10_3390_pharmaceutics12020147
crossref_primary_10_1007_s13233_016_4034_4
crossref_primary_10_1039_C4CP05122J
crossref_primary_10_1109_TMAG_2010_2046907
crossref_primary_10_1002_adhm_201300141
crossref_primary_10_3390_molecules25143159
crossref_primary_10_1016_j_ijpharm_2011_12_044
crossref_primary_10_1016_j_tiv_2017_07_022
crossref_primary_10_1109_TMAG_2012_2225024
crossref_primary_10_1166_jnn_2021_19062
crossref_primary_10_1021_la202470k
crossref_primary_10_1088_0022_3727_43_41_415504
crossref_primary_10_2478_asn_2020_0014
crossref_primary_10_1016_j_jpcs_2015_09_008
crossref_primary_10_1039_C9SM02512J
crossref_primary_10_1039_D2RA05216D
crossref_primary_10_1021_cg400627c
crossref_primary_10_1002_jbm_a_34011
crossref_primary_10_1016_j_jmmm_2015_04_030
crossref_primary_10_1016_j_jbiotec_2020_12_003
crossref_primary_10_4028_www_scientific_net_AMR_455_456_1221
crossref_primary_10_1007_s11095_011_0663_7
crossref_primary_10_1038_s41598_017_18665_4
crossref_primary_10_1039_D2TB01106A
crossref_primary_10_3109_17435390_2015_1110759
crossref_primary_10_1016_j_cbi_2018_08_027
crossref_primary_10_1007_s11051_012_1151_7
crossref_primary_10_1021_la401891f
crossref_primary_10_1016_j_saa_2017_03_056
crossref_primary_10_3390_polym3031243
crossref_primary_10_1016_j_jmmm_2010_02_019
crossref_primary_10_1007_s12035_024_04253_x
crossref_primary_10_1021_mp100273t
crossref_primary_10_1016_j_taap_2012_10_016
crossref_primary_10_1007_s10439_019_02393_z
crossref_primary_10_1038_srep11129
crossref_primary_10_1016_j_nano_2016_08_027
crossref_primary_10_1039_C9NJ05989J
crossref_primary_10_1007_s00396_014_3236_6
crossref_primary_10_3390_nano8050306
crossref_primary_10_1016_j_physe_2016_12_008
crossref_primary_10_1186_1556_276X_7_77
crossref_primary_10_1038_s41598_021_95195_0
crossref_primary_10_3389_fenrg_2020_00078
crossref_primary_10_3390_nano11102465
crossref_primary_10_1039_D2RA01139E
crossref_primary_10_1093_toxsci_kfs300
crossref_primary_10_1007_s40139_021_00227_z
crossref_primary_10_1016_j_mtchem_2021_100481
crossref_primary_10_1016_j_progpolymsci_2022_101574
crossref_primary_10_1007_s11814_016_0349_2
crossref_primary_10_1016_j_colsurfb_2017_10_048
crossref_primary_10_1007_s13273_012_0027_3
crossref_primary_10_1016_j_ijpharm_2021_120348
crossref_primary_10_2217_nnm_10_106
crossref_primary_10_1007_s11064_022_03798_4
crossref_primary_10_1007_s11434_013_6058_x
crossref_primary_10_1039_c2nr32572a
crossref_primary_10_1002_pat_4883
crossref_primary_10_1016_j_addr_2011_12_013
crossref_primary_10_1016_j_nano_2016_08_012
crossref_primary_10_1002_smll_201201531
crossref_primary_10_1021_acs_molpharmaceut_7b00109
crossref_primary_10_1002_ppsc_202000032
crossref_primary_10_1016_j_jmmm_2014_10_018
crossref_primary_10_1016_j_biomaterials_2010_07_087
crossref_primary_10_1039_C5NR01382H
crossref_primary_10_3402_nano_v1i0_5358
crossref_primary_10_3390_polym14061188
crossref_primary_10_1515_znc_2017_0110
crossref_primary_10_3389_fbioe_2020_00822
crossref_primary_10_1016_j_cherd_2014_12_016
crossref_primary_10_1039_C8IB00038G
crossref_primary_10_1088_1674_1056_22_2_027506
crossref_primary_10_1016_j_bbrep_2017_12_002
crossref_primary_10_1016_j_lfs_2021_119020
crossref_primary_10_3389_fbioe_2020_00144
crossref_primary_10_1007_s13139_020_00635_w
crossref_primary_10_1002_wnan_1905
crossref_primary_10_1016_j_jmmm_2018_09_116
crossref_primary_10_3390_molecules21101357
crossref_primary_10_1016_j_ejpb_2016_12_024
crossref_primary_10_1186_s12951_016_0168_y
crossref_primary_10_1517_17425247_2010_502560
crossref_primary_10_1186_s42833_019_0002_6
crossref_primary_10_1016_j_actbio_2011_09_013
crossref_primary_10_1002_tox_22098
crossref_primary_10_1557_jmr_2010_60
crossref_primary_10_15406_jnmr_2014_01_00004
crossref_primary_10_1016_j_jddst_2023_104295
crossref_primary_10_1155_2021_3762490
crossref_primary_10_1080_15287394_2022_2068711
crossref_primary_10_1186_1477_3155_8_25
crossref_primary_10_1063_1_4990790
crossref_primary_10_3390_molecules200916540
crossref_primary_10_1016_j_biopha_2018_09_106
crossref_primary_10_1039_C9NR08634J
crossref_primary_10_1007_s11051_017_3800_3
crossref_primary_10_1142_S1793292023500765
crossref_primary_10_1109_TMAG_2012_2222635
crossref_primary_10_1088_1674_1056_22_12_127503
crossref_primary_10_1007_s40843_017_9049_0
crossref_primary_10_1016_j_carbpol_2011_11_033
crossref_primary_10_1016_j_onano_2023_100143
crossref_primary_10_1007_s11051_010_0019_y
crossref_primary_10_1039_C5NR07144E
crossref_primary_10_3390_nano11010173
crossref_primary_10_1098_rsfs_2016_0048
crossref_primary_10_1002_pi_3078
crossref_primary_10_1088_0957_0233_21_10_105803
crossref_primary_10_1186_s13578_015_0046_6
crossref_primary_10_1002_smll_201102525
crossref_primary_10_1016_j_msec_2019_110104
crossref_primary_10_1021_acsami_7b05741
crossref_primary_10_1016_j_jcis_2018_03_008
crossref_primary_10_1134_S1063774516010107
crossref_primary_10_4103_2348_0734_131792
crossref_primary_10_4155_tde_2022_0035
crossref_primary_10_1016_j_colsurfb_2014_02_034
crossref_primary_10_3389_fbioe_2020_00922
crossref_primary_10_3390_ijms150813967
crossref_primary_10_1186_1471_2202_13_32
crossref_primary_10_1007_s11706_020_0531_7
crossref_primary_10_1002_mabi_201100150
crossref_primary_10_1016_j_snb_2019_03_030
crossref_primary_10_1016_j_apsusc_2015_08_229
crossref_primary_10_1016_j_biomaterials_2010_08_010
crossref_primary_10_1089_jop_2012_0113
crossref_primary_10_3390_ijms241210072
crossref_primary_10_1103_PhysRevB_85_045435
Cites_doi 10.1016/S0168-3659(01)00331-5
10.3109/10611869808997896
10.1039/b207789b
10.1038/74464
10.1517/14712598.3.5.745
10.1158/1078-0432.CCR-1004-0022
10.2310/7290.2006.00001
10.3233/JAD-2008-14211
10.1002/nbm.970
10.1158/1078-0432.CCR-06-0946
10.1016/0026-2862(84)90065-7
10.1586/17434440.3.4.427
10.1016/S0168-3659(98)00093-5
10.1002/pssb.200304692
10.1038/nbt1159
10.2214/ajr.152.1.167
10.1089/jam.2006.19.491
10.1016/j.jcis.2007.03.023
10.1038/nnano.2007.217
10.1102/1470-7330.2007.9001
10.1016/j.bbrc.2005.06.204
10.1076/orbi.22.1.15.14007
10.1016/S0304-8853(98)00584-8
10.1016/j.jacc.2006.06.069
10.1088/0953-8984/18/38/S24
10.1002/jgm.569
10.1093/toxsci/kfj027
10.1016/S0002-9394(14)77108-9
10.1021/la070116+
10.3109/02652049609026013
10.1016/j.jmmm.2006.10.1170
10.1016/j.jcis.2008.09.071
10.1021/cm020994n
10.1007/s10544-007-9134-7
10.1016/j.jmmm.2005.02.037
10.1016/j.jmmm.2006.10.1174
10.1021/bc000091p
10.1016/S0304-8853(98)00560-5
10.1227/01.NEU.0000175731.25414.4c
10.1007/s003300100908
10.1002/jmri.21263
10.1016/S0142-9612(03)00348-X
10.1016/S1076-6332(98)80096-2
10.1248/bpb1978.3.264
10.1007/s002530051547
10.1038/nprot.2007.352
10.1016/j.acra.2004.04.018
10.1016/S0074-7696(08)62312-8
10.1038/bjc.1989.44
10.1016/S0022-1759(01)00433-1
10.1063/1.1850855
10.1016/S0075-7535(06)32007-4
10.1016/j.jmmm.2004.10.103
10.1593/neo.05769
10.1021/la0503451
10.1016/j.jmmm.2009.02.038
10.1002/bem.2250130710
10.2217/17435889.2.3.307
10.1088/0957-4484/14/6/318
10.1038/73219
ContentType Journal Article
Copyright Copyright © 2009 American Chemical Society
Copyright_xml – notice: Copyright © 2009 American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7QO
8FD
FR3
P64
DOI 10.1021/mp900083m
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList MEDLINE
Engineering Research Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles
EISSN 1543-8392
EndPage 1428
ExternalDocumentID 19445482
10_1021_mp900083m
d205466080
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
123
4.4
53G
55A
5VS
7~N
AABXI
ABMVS
ABUCX
ACGFS
ACS
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
CS3
DU5
EBS
ED
ED~
EJD
F5P
GNL
H~9
IH9
JG
JG~
LG6
P2P
RNS
ROL
UI2
VF5
VG9
W1F
X
---
-~X
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ADHLV
AHGAQ
CITATION
CUPRZ
GGK
CGR
CUY
CVF
ECM
EIF
IHE
NPM
7X8
7QO
8FD
FR3
P64
ID FETCH-LOGICAL-a346t-221cad195751bfb34999ca2d0942fd6c288c11a27a5309068b74029a963679413
IEDL.DBID ACS
ISSN 1543-8384
IngestDate Fri Jul 11 16:20:30 EDT 2025
Thu Jul 10 18:20:51 EDT 2025
Mon Jul 21 05:33:55 EDT 2025
Tue Jul 01 04:33:28 EDT 2025
Thu Apr 24 23:02:23 EDT 2025
Thu Aug 27 13:42:20 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords phagocytosis
polyethylene oxide (PEO)
Toxicity
confocal microscopy
retinal pigment epithelial cells
polyethylene glycole (PEG)
magnetic nanoparticles
MTT assay
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a346t-221cad195751bfb34999ca2d0942fd6c288c11a27a5309068b74029a963679413
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19445482
PQID 734069611
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_754550252
proquest_miscellaneous_734069611
pubmed_primary_19445482
crossref_primary_10_1021_mp900083m
crossref_citationtrail_10_1021_mp900083m
acs_journals_10_1021_mp900083m
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
VG9
W1F
ACS
AEESW
AFEFF
ABMVS
ABUCX
IH9
BAANH
AQSVZ
ED~
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-10-05
PublicationDateYYYYMMDD 2009-10-05
PublicationDate_xml – month: 10
  year: 2009
  text: 2009-10-05
  day: 05
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Molecular pharmaceutics
PublicationTitleAlternate Mol. Pharmaceutics
PublicationYear 2009
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References Mulder W. J. (ref3/cit3) 2007; 2
Pislaru S. V. (ref16/cit16) 2006; 48
Arbab A. S. (ref61/cit61) 2006; 3
Plank C. (ref26/cit26) 2003; 3
Jordan A. (ref65/cit65) 1997; 74
Goodwin S. (ref11/cit11) 1999; 194
Harris L. A. (ref45/cit45) 2003; 15
Morana G. (ref4/cit4) 2007; 7
Jurgons R. (ref21/cit21) 2006; 18
Peters K. (ref74/cit74) 2004; 15
Morishita N. (ref28/cit28) 2005; 334
Dodd C. H. (ref68/cit68) 2001; 256
ref52/cit52
Sun H. (ref38/cit38) 2008; 10
Kim J. S. (ref60/cit60) 2006; 89
Lewin M. (ref6/cit6) 2000; 18
ref34/cit34
Schüler D. (ref55/cit55) 1999; 52
Häfeli U. O. (ref73/cit73) 1999; 194
Zhang Q. (ref46/cit46) 2007; 23
Collingwood J. F. (ref57/cit57) 2008; 14
Morimoto Y. (ref13/cit13) 1980; 3
Morales M. A. (ref36/cit36) 2005; 97
Park S. I. (ref37/cit37) 2004; 241
Wang Y. X. (ref1/cit1) 2001; 11
Mefford O. T. (ref25/cit25) 2007; 311
Choi H. (ref63/cit63) 2004; 11
Barrera C. (ref40/cit40) 2009; 329
Häfeli U. O. (ref9/cit9) 2006
Sako M. (ref10/cit10) 1985; 29
Clement O. (ref48/cit48) 1998; 5
Andrä W. (ref5/cit5) 2007
Bullok K. E. (ref70/cit70) 2006; 5
Lobel D. (ref22/cit22) 1978; 85
Asmatulu R. (ref24/cit24) 2005; 292
Holligan D. L. (ref23/cit23) 2003; 14
Gref R. (ref44/cit44) 2003
Barbon J. J. (ref51/cit51) 2007; 82
Häfeli U. O. (ref75/cit75) 2007
DeNardo S. J. (ref20/cit20) 2005; 11
Kohler N. (ref67/cit67) 2005; 21
Pulfer S. K. (ref17/cit17) 1998; 6
Kraitchman D. L. (ref7/cit7) 2008; 27
Hu F. (ref42/cit42) 2007; 311
Pieters R. (ref53/cit53) 1989; 59
Zange R. (ref72/cit72) 1998; 56
Dames P. (ref15/cit15) 2007; 2
Chouly C. (ref59/cit59) 1996; 13
Zhao H. (ref39/cit39) 2009; 321
Ally J. (ref14/cit14) 2006; 19
Gref R. (ref64/cit64) 2003; 24
Weissleder R. (ref32/cit32) 1989; 152
Liu X. Q. (ref41/cit41) 2007; 311
Weissleder R. (ref49/cit49) 2001; 12
Arbab A. S. (ref62/cit62) 2005; 18
Reddy G. R. (ref18/cit18) 2006; 12
Meyers P. H. (ref47/cit47) 1963; 90
Mykhaylyk O. (ref27/cit27) 2007; 2
Muldoon L. L. (ref58/cit58) 2005; 57
ref12/cit12
Wyllie A. H. (ref54/cit54) 1980; 68
Kirschvink J. L. (ref56/cit56) 1992; 1
Weissleder R. (ref66/cit66) 2005; 23
Mykhaylyk O. (ref30/cit30) 2008; 10
Tiefenauer L. X. (ref2/cit2) 2007
Bacon B. R. (ref31/cit31) 1987; 110
Schwalbe M. (ref71/cit71) 2005; 293
Holland D. (ref50/cit50) 2003; 22
ref33/cit33
Hyeon T. (ref35/cit35) 2003; 8
Montet X. (ref69/cit69) 2006; 8
Weissleder R. (ref8/cit8) 2000; 6
Gersting S. W. (ref29/cit29) 2004; 6
Greenwald R. B. (ref43/cit43) 2001; 74
Driscoll C. F. (ref19/cit19) 1984; 27
References_xml – volume: 10
  start-page: 493
  year: 2008
  ident: ref30/cit30
  publication-title: Curr. Opin. Mol. Ther.
– volume: 74
  start-page: 159
  year: 2001
  ident: ref43/cit43
  publication-title: J. Controlled Release
  doi: 10.1016/S0168-3659(01)00331-5
– volume: 6
  start-page: 215
  year: 1998
  ident: ref17/cit17
  publication-title: J. Drug Targeting
  doi: 10.3109/10611869808997896
– volume: 8
  start-page: 927
  year: 2003
  ident: ref35/cit35
  publication-title: Chem. Commun.
  doi: 10.1039/b207789b
– volume: 18
  start-page: 410
  year: 2000
  ident: ref6/cit6
  publication-title: Nat. Biotechnol.
  doi: 10.1038/74464
– volume: 3
  start-page: 745
  year: 2003
  ident: ref26/cit26
  publication-title: Expert Opin. Biol. Ther.
  doi: 10.1517/14712598.3.5.745
– volume: 11
  start-page: 7087s
  year: 2005
  ident: ref20/cit20
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-1004-0022
– volume: 5
  start-page: 1
  year: 2006
  ident: ref70/cit70
  publication-title: Mol. Imaging
  doi: 10.2310/7290.2006.00001
– volume: 14
  start-page: 235
  year: 2008
  ident: ref57/cit57
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-2008-14211
– volume-title: Magnetism in Medicine: A Handbook
  year: 2007
  ident: ref5/cit5
– volume: 18
  start-page: 383
  year: 2005
  ident: ref62/cit62
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.970
– volume: 12
  start-page: 6677
  year: 2006
  ident: ref18/cit18
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-06-0946
– volume: 27
  start-page: 353
  year: 1984
  ident: ref19/cit19
  publication-title: Microvasc. Res.
  doi: 10.1016/0026-2862(84)90065-7
– ident: ref33/cit33
– volume: 3
  start-page: 427
  year: 2006
  ident: ref61/cit61
  publication-title: Expert Rev. Med. Devices
  doi: 10.1586/17434440.3.4.427
– volume: 56
  start-page: 249
  year: 1998
  ident: ref72/cit72
  publication-title: J. Controlled Release
  doi: 10.1016/S0168-3659(98)00093-5
– volume: 241
  start-page: 1662
  year: 2004
  ident: ref37/cit37
  publication-title: Phys. Status Solidi B
  doi: 10.1002/pssb.200304692
– volume: 23
  start-page: 1418
  year: 2005
  ident: ref66/cit66
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1159
– ident: ref12/cit12
– volume: 152
  start-page: 167
  year: 1989
  ident: ref32/cit32
  publication-title: Am. J. Roentgenol.
  doi: 10.2214/ajr.152.1.167
– volume: 19
  start-page: 491
  year: 2006
  ident: ref14/cit14
  publication-title: J. Aerosol Med.
  doi: 10.1089/jam.2006.19.491
– volume: 311
  start-page: 469
  year: 2007
  ident: ref42/cit42
  publication-title: J. Colloid Interface Sci.
  doi: 10.1016/j.jcis.2007.03.023
– volume: 2
  start-page: 495
  year: 2007
  ident: ref15/cit15
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2007.217
– volume: 7
  start-page: S24
  year: 2007
  ident: ref4/cit4
  publication-title: Cancer Imaging
  doi: 10.1102/1470-7330.2007.9001
– volume: 334
  start-page: 1121
  year: 2005
  ident: ref28/cit28
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2005.06.204
– volume: 22
  start-page: 15
  year: 2003
  ident: ref50/cit50
  publication-title: Orbit
  doi: 10.1076/orbi.22.1.15.14007
– volume: 194
  start-page: 132
  year: 1999
  ident: ref11/cit11
  publication-title: J. Magn. Magn. Mater.
  doi: 10.1016/S0304-8853(98)00584-8
– volume: 48
  start-page: 1839
  year: 2006
  ident: ref16/cit16
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2006.06.069
– volume: 18
  start-page: S2893
  year: 2006
  ident: ref21/cit21
  publication-title: J. Phys. Condens. Matter
  doi: 10.1088/0953-8984/18/38/S24
– volume: 6
  start-page: 913
  year: 2004
  ident: ref29/cit29
  publication-title: J. Gene Med.
  doi: 10.1002/jgm.569
– volume: 89
  start-page: 338
  year: 2006
  ident: ref60/cit60
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/kfj027
– volume: 85
  start-page: 699
  year: 1978
  ident: ref22/cit22
  publication-title: Am. J. Ophthalmol.
  doi: 10.1016/S0002-9394(14)77108-9
– volume: 23
  start-page: 6927
  year: 2007
  ident: ref46/cit46
  publication-title: Langmuir
  doi: 10.1021/la070116+
– volume: 13
  start-page: 245
  year: 1996
  ident: ref59/cit59
  publication-title: J. Microencapsul.
  doi: 10.3109/02652049609026013
– volume: 311
  start-page: 84
  year: 2007
  ident: ref41/cit41
  publication-title: J. Magn. Magn. Mater.
  doi: 10.1016/j.jmmm.2006.10.1170
– volume: 329
  start-page: 107
  year: 2009
  ident: ref40/cit40
  publication-title: J. Colloid Interface Sci.
  doi: 10.1016/j.jcis.2008.09.071
– volume: 15
  start-page: 1367
  year: 2003
  ident: ref45/cit45
  publication-title: Chem. Mater.
  doi: 10.1021/cm020994n
– volume: 10
  start-page: 281
  year: 2008
  ident: ref38/cit38
  publication-title: Biomed. Microdevices
  doi: 10.1007/s10544-007-9134-7
– volume: 293
  start-page: 433
  year: 2005
  ident: ref71/cit71
  publication-title: J. Magn. Magn. Mater.
  doi: 10.1016/j.jmmm.2005.02.037
– volume: 15
  start-page: 321
  year: 2004
  ident: ref74/cit74
  publication-title: J. Mater. Sci.: Mater. Med.
– volume: 90
  start-page: 1068
  year: 1963
  ident: ref47/cit47
  publication-title: Am. J. Roentgenol. Radium Ther. Nucl. Med.
– volume: 311
  start-page: 347Z
  year: 2007
  ident: ref25/cit25
  publication-title: J. Magn. Magn. Mater.
  doi: 10.1016/j.jmmm.2006.10.1174
– volume: 12
  start-page: 213
  year: 2001
  ident: ref49/cit49
  publication-title: Bioconjugate Chem.
  doi: 10.1021/bc000091p
– volume: 194
  start-page: 76
  year: 1999
  ident: ref73/cit73
  publication-title: J. Magn. Magn. Mater.
  doi: 10.1016/S0304-8853(98)00560-5
– volume: 57
  start-page: 785
  year: 2005
  ident: ref58/cit58
  publication-title: Neurosurgery
  doi: 10.1227/01.NEU.0000175731.25414.4c
– volume: 11
  start-page: 2319
  year: 2001
  ident: ref1/cit1
  publication-title: Eur. Radiol.
  doi: 10.1007/s003300100908
– start-page: 1
  volume-title: Nanotechnology in Biology and Medicine: Methods, Devices, and Applications
  year: 2007
  ident: ref2/cit2
– volume: 27
  start-page: 299
  year: 2008
  ident: ref7/cit7
  publication-title: J. Magn. Reson. Imaging
  doi: 10.1002/jmri.21263
– start-page: 77
  volume-title: Smart Nanoparticles in Nanomedicine: the MML Series
  year: 2006
  ident: ref9/cit9
– volume: 82
  start-page: 715
  year: 2007
  ident: ref51/cit51
  publication-title: Arch. Soc. Esp. Oftalmol.
– volume: 74
  start-page: 32
  year: 1997
  ident: ref65/cit65
  publication-title: Eur. J. Cell Biol.
– volume: 24
  start-page: 4529
  year: 2003
  ident: ref64/cit64
  publication-title: Biomater.
  doi: 10.1016/S0142-9612(03)00348-X
– volume: 5
  start-page: S170
  year: 1998
  ident: ref48/cit48
  publication-title: Acad. Radiol.
  doi: 10.1016/S1076-6332(98)80096-2
– volume: 3
  start-page: 264
  year: 1980
  ident: ref13/cit13
  publication-title: J. Pharmacobio-Dyn.
  doi: 10.1248/bpb1978.3.264
– volume: 52
  start-page: 464
  year: 1999
  ident: ref55/cit55
  publication-title: Appl. Microbiol. Biotechnol.
  doi: 10.1007/s002530051547
– volume: 29
  start-page: 200
  year: 1985
  ident: ref10/cit10
  publication-title: Ann. Radiol.
– volume: 2
  start-page: 2391
  year: 2007
  ident: ref27/cit27
  publication-title: Nat. Protocols
  doi: 10.1038/nprot.2007.352
– volume: 11
  start-page: 996
  year: 2004
  ident: ref63/cit63
  publication-title: Acad. Radiol.
  doi: 10.1016/j.acra.2004.04.018
– volume: 68
  start-page: 251
  year: 1980
  ident: ref54/cit54
  publication-title: Int. Rev. Cytol.
  doi: 10.1016/S0074-7696(08)62312-8
– volume: 110
  start-page: 164
  year: 1987
  ident: ref31/cit31
  publication-title: J. Lab. Clin. Med.
– ident: ref34/cit34
– volume: 59
  start-page: 217
  year: 1989
  ident: ref53/cit53
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.1989.44
– volume: 256
  start-page: 89
  year: 2001
  ident: ref68/cit68
  publication-title: J. Immunol. Methods
  doi: 10.1016/S0022-1759(01)00433-1
– volume-title: Synthesis, Functionalization and Surface Treatment of Nanoparticles
  year: 2003
  ident: ref44/cit44
– volume: 97
  start-page: 10Q905
  year: 2005
  ident: ref36/cit36
  publication-title: J. Appl. Phys.
  doi: 10.1063/1.1850855
– start-page: 163
  volume-title: Magnetic Cell Separation
  year: 2007
  ident: ref75/cit75
  doi: 10.1016/S0075-7535(06)32007-4
– volume: 292
  start-page: 108
  year: 2005
  ident: ref24/cit24
  publication-title: J. Magn. Magn. Mater.
  doi: 10.1016/j.jmmm.2004.10.103
– volume: 8
  start-page: 214
  year: 2006
  ident: ref69/cit69
  publication-title: Neoplasia
  doi: 10.1593/neo.05769
– volume: 21
  start-page: 8858
  year: 2005
  ident: ref67/cit67
  publication-title: Langmuir
  doi: 10.1021/la0503451
– volume: 321
  start-page: 1356
  year: 2009
  ident: ref39/cit39
  publication-title: J. Magn. Magn. Mater.
  doi: 10.1016/j.jmmm.2009.02.038
– ident: ref52/cit52
– volume: 1
  start-page: 101
  year: 1992
  ident: ref56/cit56
  publication-title: Bioelectromagnetics
  doi: 10.1002/bem.2250130710
– volume: 2
  start-page: 307
  year: 2007
  ident: ref3/cit3
  publication-title: Nanomed.
  doi: 10.2217/17435889.2.3.307
– volume: 14
  start-page: 661
  year: 2003
  ident: ref23/cit23
  publication-title: Nanotechnology
  doi: 10.1088/0957-4484/14/6/318
– volume: 6
  start-page: 351
  year: 2000
  ident: ref8/cit8
  publication-title: Nat. Med.
  doi: 10.1038/73219
SSID ssj0024523
Score 2.3978732
Snippet Magnetic targeting is useful for intravascular or intracavitary drug delivery, including tumor chemotherapy or intraocular antiangiogenic therapy. For all such...
SourceID proquest
pubmed
crossref
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1417
SubjectTerms Biological Transport, Active
Cell Line, Tumor
Cell Survival - drug effects
Cells, Cultured
Drug Delivery Systems
Endothelial Cells - drug effects
Ferrosoferric Oxide - administration & dosage
Ferrosoferric Oxide - pharmacokinetics
Ferrosoferric Oxide - toxicity
Humans
Male
Materials Testing
Metal Nanoparticles - administration & dosage
Metal Nanoparticles - chemistry
Metal Nanoparticles - toxicity
Metal Nanoparticles - ultrastructure
Microscopy, Electron, Transmission
Nanotechnology
Particle Size
Polyethylene Glycols - chemistry
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - pathology
Retinal Pigment Epithelium - cytology
Retinal Pigment Epithelium - drug effects
Title Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery
URI http://dx.doi.org/10.1021/mp900083m
https://www.ncbi.nlm.nih.gov/pubmed/19445482
https://www.proquest.com/docview/734069611
https://www.proquest.com/docview/754550252
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT9tAEB5RuPTSFkrbtAWNWoR6wJR9eL17REkRQqJCIkHcrN31GkUEO0psqemv767tkFblcR_Lj53xfKOZ7xuAPW5yroyJI-tzU8SNEZGMMxk5ro2TmUpYHtjI5z_F6YifXcfXa_D1kQ4-Jd_vpqoBCncvYIMKSUKFddy_XAnqxc0ONw8FWCSZ5Ev5oL8vDanHzv9NPY_gySavnLyGwZKd046T3B7WlTm0v_8Xa3zqkd_Aqw5X4nHrCJuw5oot2L9ohakXBzhc8azmB7iPFyvJ6sVbuOq7yQRH00rfOtRFhuMCr8bVrMRh-WtsPVLHMsdzfVMEziP6X7KvtbuROrysx1UgYKHHvziY1Tc4cJMw7rHYhtHJj2H_NOo2LkSacVFFlBKrM6JCM8bkhoVyyGqa-RqQ5pmwVEpLiKaJjtmROhLSJL7-VNpHsfCBTdg7WC_Kwn0ADKJARDMXM2q40E5RaiVVxCrjEVuierDrjyTtImaeNs1wStL7b9eDb8vTSm2nVx7WZkweMv1ybzptRToeMsLlkac-hEJfRBeurOdpwgL9VxDyhEkc2N80pj1433rL6kaKc1_20Y_PvdAneNm0oprpg8-wXs1qt-MRTWV2G4_-A6Cv7ak
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1NT9wwELVaOLSXUmgL21I6qirUAwH8kcQ-VkvRtmUREruIW2Q7DlqxJKtNIrH99dhOlpSKftwniRN7Mm80894g9ImpjAmlwkDb2BQwpaKAhykPDJPK8FTENHNs5OFpNBiz75fhZSuT47gwdhGlvVPpi_idugA-uJkJjxdunqJVr4DiYFD_vNPVC_0oN4sIaMApZ0sVoV8vdRFIlw8j0B9gpQ8vx2vNnCK_MN9Vcr1fV2pf__xNs_H_Vv4SvWhRJnxpjsU6emLyDbR71shUL_Zg1LGuyj3YhbNOwHrxCl30zXQK41klrw3IPIVJDheTal7AqLidaIvbochgKK9yx4AE-4O2mXfbYAfn9aRydCywaBiO5vUVHJmpa_5YvEbj46-j_iBo5y8EkrKoCgjBWqZYuNKMyhR1yZGWJLUZIcnSSBPONcaSxDKkh-Iw4iq22aiQ1qcj6-aYvkEreZGbLQROIghLakJKFIukEYRoTgTWQln8Fose2rGfLmn9p0x8aZzg5P7b9dDn5aYlulUvd0M0po-Zfrw3nTWSHY8ZwXLnE-tQrkoic1PUZRJTRwaOMP6LSei44CQkPbTZHJruQYIxmwSSt_96oQ_o2WA0PElOvp3-eIee-yKV70vYRivVvDbvLdap1I4_5HfvhPYU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bT9swFLY2Jk17GezesbGjaUJ7IIBvif2I2lXsAqtEi3iLbMdBFSWpmkSi_PrZbtpuE7u8n8SO7ZPzHZ3zfUboA9M5k1rzyLjYFDGt40jwTESWKW1FJhOaezbyyWl8PGJfLvhFmyh6LoybROXeVIUivvfqaZa3CgP44HoqA2a4vo8ecC_95qFQ92ytrcfDdW4OFdBIUMGWSkI_P-qjkKl-jUJ_gJYhxPQ30ffV5EJnydV-U-t9c_ubbuP_z34LPW7RJhwtjscTdM8WT9HuYCFXPd-D4Zp9Ve3BLgzWQtbzZ-i8aycTGE1rdWVBFRmMCzgf17MShuXN2Dj8DmUOJ-qy8ExIcD9ql4G3jXZw1oxrT8sCh4qhN2suoWcnvglk_hyN-p-G3eOovYchUpTFdUQINirD0pdodK6pT5KMIpnLDEmexYYIYTBWJFGcHsrDWOjEZaVSOd-Onbtj-gJtFGVhXyHwUkFYUcsp0SxWVhJiBJHYSO1wXCI7aMctX9r6UZWGEjnB6WrtOujjcuNS06qY-8s0JneZvl-ZThfSHXcZwXL3U-dYvlqiCls2VZpQTwqOMf6LCfeccMJJB71cHJz1QJIxlwyS1__6oHfo4aDXT799Pv26jR6FWlVoT3iDNupZY986yFPrnXDOfwD2uPiO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell+uptake+and+in+vitro+toxicity+of+magnetic+nanoparticles+suitable+for+drug+delivery&rft.jtitle=Molecular+pharmaceutics&rft.au=H%C3%A4feli%2C+Urs+O&rft.au=Riffle%2C+Judy+S&rft.au=Harris-Shekhawat%2C+Linda&rft.au=Carmichael-Baranauskas%2C+Anita&rft.date=2009-10-05&rft.issn=1543-8384&rft.volume=6&rft.issue=5&rft.spage=1417&rft_id=info:doi/10.1021%2Fmp900083m&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1543-8384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1543-8384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1543-8384&client=summon